Want to see TEVA full AI Analyst Report?
Total Valuation
Teva has a market cap or net worth of $48.77B. The enterprise value is $154.00B.
Market Cap$48.77B
Enterprise Value$154.00B
Share Statistics
Teva has 1,165,296,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,165,296,100
Owned by Insiders―
Owned by Institutions0.23%
Financial Efficiency
Teva’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is 14.69%.
Return on Equity (ROE)0.19
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)14.69%
Return on Capital Employed (ROCE)0.16
Revenue Per Employee560.23K
Profits Per Employee45.80K
Employee Count33,346
Asset Turnover0.46
Inventory Turnover2.85
Valuation Ratios
The current PE Ratio of Teva is 68.1. Teva’s PEG ratio is -0.14.
PE Ratio68.1
PS Ratio1.94
PB Ratio4.58
Price to FCF14.18
Price to Operating Cash Flow16.50
PEG Ratio-0.14
Income Statement
In the last 12 months, Teva had revenue of 18.68B and earned 1.53B in profits. Earnings per share was 1.23.
Revenue18.68B
Gross Profit9.63B
Operating Income4.28B
Pretax Income1.34B
Net Income1.53B
EBITDA3.34B
Earnings Per Share (EPS)1.23
Cash Flow
In the last 12 months, operating cash flow was 2.93B and capital expenditures -551.37M, giving a free cash flow of 2.38B billion.
Operating Cash Flow2.93B
Free Cash Flow2.38B
Free Cash Flow per Share2.04
Dividends & Yields
Teva pays an annual dividend of $0.085, resulting in a dividend yield of 5.8%
Dividend Per Share$0.085
Dividend Yield5.8%
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.54
52-Week Price Change104.15%
50-Day Moving Average38.12
200-Day Moving Average31.83
Relative Strength Index (RSI)66.18
Average Volume (3m)5.24M
Important Dates
Teva upcoming earnings date is Nov 3, 2026, Before Open (Confirmed).
Last Earnings DateJul 29, 2026
Next Earnings DateNov 3, 2026
Ex-Dividend Date―
Financial Position
Teva as a current ratio of 1.04, with Debt / Equity ratio of 216.19%
Current Ratio1.04
Quick Ratio0.80
Debt to Market Cap0.46
Net Debt to EBITDA4.14
Interest Coverage Ratio4.23
Taxes
In the past 12 months, Teva has paid -194.84M in taxes.
Income Tax-194.84M
Effective Tax Rate-0.15
Enterprise Valuation
Teva EV to EBITDA ratio is 15.00, with an EV/FCF ratio of 19.59.
EV to Sales2.68
EV to EBITDA15.00
EV to Free Cash Flow19.59
EV to Operating Cash Flow16.16
Balance Sheet
Teva has $3.63B in cash and marketable securities with $16.76B in debt, giving a net cash position of -$13.13B billion.
Cash & Marketable Securities$3.63B
Total Debt$16.76B
Net Cash-$13.13B
Net Cash Per Share-$11.27
Tangible Book Value Per Share-$10.37
Margins
Gross margin is 52.46%, with operating margin of 22.90%, and net profit margin of 8.18%.
Gross Margin52.46%
Operating Margin22.90%
Pretax Margin7.17%
Net Profit Margin8.18%
EBITDA Margin17.87%
EBIT Margin12.50%
Analyst Forecast
The average price target for Teva is $48.38, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$48.38
Price Target Upside26.99% Upside
Analyst ConsensusStrong Buy
Analyst Count9
Revenue Growth Forecast4.40%
EPS Growth Forecast―